RecruitingNot ApplicableNCT07431788

The Effect of Uterine Manipulator Use During Abdominal Hysterectomy on Postoperative Sexual Function

A Prospective Randomized Controlled Trial Evaluating the Impact of Uterine Manipulator Use During Total Abdominal Hysterectomy on Postoperative Female Sexual Function

Sponsor

Erkan Gol

Enrollment

60 participants

Start Date

Mar 2, 2026

Study Type

INTERVENTIONAL

Conditions

Leiomyoma (Uterine Fibroids)Adenomyoma of Uterus Uterine Bleeding

Summary

This prospective, single-center, randomized controlled trial aims to evaluate the effect of uterine manipulator use during total abdominal hysterectomy on postoperative female sexual function at 3 months, assessed by the Female Sexual Function Index (FSFI). Secondary outcomes include operative time, perioperative hemoglobin change, postoperative pain (VAS), hospital stay duration, and 30-day complications.

Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study examines whether using a uterine manipulator (a tool inserted through the vagina to help position the uterus during surgery) during open abdominal hysterectomy affects sexual function after the procedure. **You may be eligible if...** - You are a woman aged 18 or older - You are scheduled for a total abdominal hysterectomy (removal of the uterus through the abdomen) for a non-cancerous reason - You have been sexually active in the past 4 weeks - You are able to complete a standardised sexual function questionnaire - You have provided written consent **You may NOT be eligible if...** - You have a gynaecological cancer - You have had a previous hysterectomy - You are pregnant - You have a condition that already significantly affects sexual function Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.